Uncertain benefit: the public policy of approving smallpox vaccine research
- PMID: 15249295
- PMCID: PMC1448369
- DOI: 10.2105/ajph.94.6.943
Uncertain benefit: the public policy of approving smallpox vaccine research
Abstract
Without an accurate assessment of the prospect of bioterrorist attack, it is especially challenging to evaluate the protocols for testing smallpox vaccines in the pediatric population. Usual regulatory mechanisms cannot shepherd research protocols with benefits that can only be characterized as "uncertain" in the face of more than minimal risk. When a protocol is placed in a government forum for analysis, the public has a unique opportunity to debate the balancing of research risks and benefits on behalf of children who are unable to assent to research themselves, as well as to express views about vaccination policy broadly. This model for review of pediatric research that may be without benefit will be especially important as challenging studies of various vaccines against a range of infectious properties, such as anthrax and severe acute respiratory syndrome (SARS), emerge.
References
-
- Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Draft supplemental recommendation of the ACIP: use of smallpox (vaccinia) vaccine. June 2002. Available at: http://www.cdc.gov/nip/smallpox/supp_recs.htm. Accessed January 2003.
-
- Neff JM. The case for abolishing routine childhood smallpox vaccination in the United States. Am J Epidemiol. 1971;93:245–247. - PubMed
-
- Gellman B. 4 nations thought to possess smallpox. Washington Post. 5November2002;A1.
-
- Office for Human Rights Protections. US Department of Health and Human Services Web site. A multicenter, randomized dose response study of the safety, clinical and immune responses of Dryvax administered to children 2 to 5 years of age. Available at: http://ohrp.osophs.dhhs.gov/dpanel/tdryvax.pdf. Accessed November 11, 2002.
-
- Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. JAMA. 1999;281:2127–2137. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
